Praxis SCN2A Programs: An Update

Post author:David Cunnington
Post published:May 2, 2021
Post category:Conference 2021
Post comments:0 Comments

Michael Oldham and Devra Densmore discuss Praxis' rare epilepsy pipeline, specifically for SCN2A including precision based approaches.

Loss of function gene mutations in SCN2A: Implications and opportunities for therapeutic intervention

Post author:David Cunnington
Post published:April 14, 2021
Post category:Conference 2021
Post comments:0 Comments

Professor Steven Petrou explains how mutations in the SCN2A gene can lead to loss of function, and how treatments could increase function.

Developing Treatment for SCN2A

Post author:SCN2A Australia
Post published:November 23, 2019
Post category:Webinar
Post comments:0 Comments

Prof Steven Petrou and Dr Kiran Reddy discuss the RC-222 program developing an ASO treatment for gain-of-function SCN2A epilepsies.

Developing Treatments for SCN2A

Post author:SCN2A Australia
Post published:November 10, 2019
Post category:Podcast
Post comments:0 Comments

We talk with Dr Kiran Reddy about the plans for the RC-222 treatment program with the goal of developing a treatment for SCN2A gain-of-function epilepsies.